Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02012374 · ClinicalTrials.gov registry record · NA

Overcoming Learned Non-Use in Chronic Aphasia

A NA study, sponsored by University of Massachusetts, Amherst.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT02012374: Completed NA study, sponsored by University of Massachusetts, Amherst.

NCT02012374 is a NA study that has completed, run by University of Massachusetts, Amherst. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02012374, a NA study, has completed, sponsored by University of Massachusetts, Amherst.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

In this study the investigators are examining the effectiveness of intensive speech therapy in chronic moderate-to-severe stroke-induced aphasia under two conditions - responses "constrained" or unconstrained to speech. Both treatments involve massed practice communicating, using intensive language action therapy 3 hours/day, 5 days/week for two weeks, followed by six months of a home practice program. One treatment stresses spoken responses as the preferred expressive modality during intensive therapy. Before and after treatment, and following the home practice program and a period of no practice, the investigators will administer several tests and discourse samples to examine changes associated with the treatments. Participants will also undergo structural and functional MRI testing at these time points. The investigators will also attempt to quantify the degree to which improvements following intensive language therapy and home practice correlate with changes in Quality of Life measures as perceived by both participants with aphasia and their significant others. It is hypothesized that, whereas both treatments will lead to improvements in naming practiced words and communicating, outcomes will be enhanced for the group randomly assigned to the "constraint" condition. Moreover, performance will be enhanced on words practiced during the home practice program, including those that were not practiced during intensive therapy. Improved naming will correlate with modulation of 'signature' language and attentional networks, whose variability will depend on remaining viable brain structures. Initial severity and site/extent of lesion should predict patients' ability to transfer gains in naming to improvements in discourse.

Interventions

  • BEHAVIORAL Intensive Language Action Therapy

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2012-02-26
Est. Completion 2015-07-09
Phase NA

What the finished NCT02012374 record still lists

NCT02012374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Intensive Language Action Therapy is the first listed.

NCT02012374 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02012374 about?

NCT02012374 is a clinical study titled "Overcoming Learned Non-Use in Chronic Aphasia". In this study the investigators are examining the effectiveness of intensive speech therapy in chronic moderate-to-severe stroke-induced aphasia under two conditions - responses "constrained" or unconstrained to speech. Both treatments involve massed practice communicating, using intensive language ...

What is the current status of trial NCT02012374?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2012-02-26. Estimated completion is 2015-07-09.

What interventions are being tested in trial NCT02012374?

The interventions under investigation include: Intensive Language Action Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02012374?

This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02012374's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02012374, the US trial registry maintained by the National Library of Medicine. NCT02012374 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.